Acuitas Investments, LLC Harvard Bioscience Inc Transaction History
Acuitas Investments, LLC
- $98.9 Million
- Q1 2025
A detailed history of Acuitas Investments, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Acuitas Investments, LLC holds 491,092 shares of HBIO stock, worth $171,882. This represents 0.28% of its overall portfolio holdings.
Number of Shares
491,092
Previous 491,092
-0.0%
Holding current value
$171,882
Previous $1.04 Million
73.07%
% of portfolio
0.28%
Previous 0.98%
Shares
10 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
26.1MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.39MShares$1.19 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$995,2770.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$765,6250.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$748,5620.0% of portfolio
-
Royce & Associates LP1.78MShares$622,2620.01% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $14.6M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...